KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesOther Gross PP&E AdjustmentsReceivables RefundsShares IssuedShares Outstanding
Ratios

Co-Diagnostics (CODX) Leases (2022 - 2025)

Historic Leases for Co-Diagnostics (CODX) over the last 4 years, with Q3 2025 value amounting to $1.4 million.

  • Co-Diagnostics' Leases fell 3828.31% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 3828.31%. This contributed to the annual value of $2.1 million for FY2024, which is 2871.46% down from last year.
  • Per Co-Diagnostics' latest filing, its Leases stood at $1.4 million for Q3 2025, which was down 3828.31% from $1.7 million recorded in Q2 2025.
  • In the past 5 years, Co-Diagnostics' Leases ranged from a high of $3.2 million in Q2 2023 and a low of $372115.0 during Q4 2022
  • Its 4-year average for Leases is $1.8 million, with a median of $1.9 million in 2025.
  • As far as peak fluctuations go, Co-Diagnostics' Leases skyrocketed by 69727.34% in 2023, and later plummeted by 3828.31% in 2025.
  • Quarter analysis of 4 years shows Co-Diagnostics' Leases stood at $372115.0 in 2022, then soared by 697.27% to $3.0 million in 2023, then decreased by 28.71% to $2.1 million in 2024, then crashed by 31.92% to $1.4 million in 2025.
  • Its Leases was $1.4 million in Q3 2025, compared to $1.7 million in Q2 2025 and $1.9 million in Q1 2025.